Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKIIδ oxidation
- PMID: 31243295
- PMCID: PMC6595001
- DOI: 10.1038/s41598-019-45743-6
Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKIIδ oxidation
Abstract
Reactive oxygen species (ROS) contribute to myocardial death during ischemia-reperfusion (I/R) injury, but detailed knowledge of molecular pathways connecting ROS to cardiac injury is lacking. Activation of the Ca2+/calmodulin-dependent protein kinase II (CaMKIIδ) is implicated in myocardial death, and CaMKII can be activated by ROS (ox-CaMKII) through oxidation of regulatory domain methionines (Met281/282). We examined I/R injury in mice where CaMKIIδ was made resistant to ROS activation by knock-in replacement of regulatory domain methionines with valines (MMVV). We found reduced myocardial death, and improved left ventricular function 24 hours after I/R injury in MMVV in vivo and in vitro compared to WT controls. Loss of ATP sensitive K+ channel (KATP) current contributes to I/R injury, and CaMKII promotes sequestration of KATP from myocardial cell membranes. KATP current density was significantly reduced by H2O2 in WT ventricular myocytes, but not in MMVV, showing ox-CaMKII decreases KATP availability. Taken together, these findings support a view that ox-CaMKII and KATP are components of a signaling axis promoting I/R injury by ROS.
Conflict of interest statement
M.E. Anderson is a cofounder of Allosteros Therapeutics, a biotech company developing CaMKII inhibitor drugs to treat cardiovascular disease.
Figures





Similar articles
-
CaMKII and reactive oxygen species contribute to early reperfusion arrhythmias, but oxidation of CaMKIIδ at methionines 281/282 is not a determining factor.J Mol Cell Cardiol. 2023 Feb;175:49-61. doi: 10.1016/j.yjmcc.2022.12.002. Epub 2022 Dec 14. J Mol Cell Cardiol. 2023. PMID: 36528076
-
CaMKIIδ Met281/282 oxidation is not required for recovery of calcium transients during acidosis.Am J Physiol Heart Circ Physiol. 2021 Mar 1;320(3):H1199-H1212. doi: 10.1152/ajpheart.00040.2020. Epub 2021 Jan 15. Am J Physiol Heart Circ Physiol. 2021. PMID: 33449853
-
Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.Circ Res. 2013 Mar 15;112(6):935-44. doi: 10.1161/CIRCRESAHA.112.276915. Epub 2013 Feb 6. Circ Res. 2013. PMID: 23388157 Free PMC article.
-
CaMKII, 'jack of all trades' in inflammation during cardiac ischemia/reperfusion injury.J Mol Cell Cardiol. 2023 Nov;184:48-60. doi: 10.1016/j.yjmcc.2023.10.003. Epub 2023 Oct 7. J Mol Cell Cardiol. 2023. PMID: 37813179 Review.
-
CaMKIIδ and cardiomyocyte Ca(2+) signalling new perspectives on splice variant targeting.Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1327-32. doi: 10.1111/1440-1681.12489. Clin Exp Pharmacol Physiol. 2015. PMID: 26361740 Review.
Cited by
-
CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies.Drug Des Devel Ther. 2024 Aug 5;18:3461-3476. doi: 10.2147/DDDT.S473251. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39132626 Free PMC article. Review.
-
Myocardial oxidative stress is increased in early reperfusion, but systemic antioxidative therapy does not prevent ischemia-reperfusion arrhythmias in pigs.Front Cardiovasc Med. 2023 Sep 26;10:1223496. doi: 10.3389/fcvm.2023.1223496. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37823177 Free PMC article.
-
CaMKII as a Therapeutic Target in Cardiovascular Disease.Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:249-272. doi: 10.1146/annurev-pharmtox-051421-111814. Epub 2022 Aug 16. Annu Rev Pharmacol Toxicol. 2023. PMID: 35973713 Free PMC article. Review.
-
In vivo gene editing of CAMKIID: out with the bad and in with the good.J Clin Invest. 2024 Jan 2;134(1):e176672. doi: 10.1172/JCI176672. J Clin Invest. 2024. PMID: 38165033 Free PMC article.
-
CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure.Front Cardiovasc Med. 2022 Jan 20;8:820416. doi: 10.3389/fcvm.2021.820416. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35127874 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous